How Ebola and Marburg viruses battle the immune system - PubMed (original) (raw)
Review
doi: 10.1038/nri2098.
Affiliations
- PMID: 17589545
- DOI: 10.1038/nri2098
Review
How Ebola and Marburg viruses battle the immune system
Mansour Mohamadzadeh et al. Nat Rev Immunol. 2007 Jul.
Abstract
The filoviruses Ebola and Marburg have emerged in the past decade from relative obscurity to serve now as archetypes for some of the more intriguing and daunting challenges posed by such agents. Public imagination is captured by deadly outbreaks of these viruses and reinforced by the specter of bioterrorism. As research on these agents has accelerated, it has been found increasingly that filoviruses use a combination of familiar and apparently new ways to baffle and battle the immune system. Filoviruses have provided thereby a new lens through which to examine the immune system itself.
Similar articles
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW. Jones SM, et al. Nat Med. 2005 Jul;11(7):786-90. doi: 10.1038/nm1258. Epub 2005 Jun 5. Nat Med. 2005. PMID: 15937495 - A single shot against Ebola and Marburg virus.
Baize S. Baize S. Nat Med. 2005 Jul;11(7):720-1. doi: 10.1038/nm0705-720. Nat Med. 2005. PMID: 16015361 No abstract available. - Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
Warfield KL, Swenson DL, Negley DL, Schmaljohn AL, Aman MJ, Bavari S. Warfield KL, et al. Vaccine. 2004 Sep 3;22(25-26):3495-502. doi: 10.1016/j.vaccine.2004.01.063. Vaccine. 2004. PMID: 15308377 - Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
Grant-Klein RJ, Altamura LA, Schmaljohn CS. Grant-Klein RJ, et al. Virus Res. 2011 Dec;162(1-2):148-61. doi: 10.1016/j.virusres.2011.09.005. Epub 2011 Sep 10. Virus Res. 2011. PMID: 21925552 Review. - DNA vaccines for biodefense.
Dupuy LC, Schmaljohn CS. Dupuy LC, et al. Expert Rev Vaccines. 2009 Dec;8(12):1739-54. doi: 10.1586/erv.09.132. Expert Rev Vaccines. 2009. PMID: 19943766 Review.
Cited by
- Disease modeling for Ebola and Marburg viruses.
Bente D, Gren J, Strong JE, Feldmann H. Bente D, et al. Dis Model Mech. 2009 Jan-Feb;2(1-2):12-7. doi: 10.1242/dmm.000471. Dis Model Mech. 2009. PMID: 19132113 Free PMC article. - Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.
Cilloniz C, Ebihara H, Ni C, Neumann G, Korth MJ, Kelly SM, Kawaoka Y, Feldmann H, Katze MG. Cilloniz C, et al. J Virol. 2011 Sep;85(17):9060-8. doi: 10.1128/JVI.00659-11. Epub 2011 Jul 6. J Virol. 2011. PMID: 21734050 Free PMC article. - Ebola virus disease: a highly fatal infectious disease reemerging in West Africa.
To KK, Chan JF, Tsang AK, Cheng VC, Yuen KY. To KK, et al. Microbes Infect. 2015 Feb;17(2):84-97. doi: 10.1016/j.micinf.2014.11.007. Epub 2014 Nov 29. Microbes Infect. 2015. PMID: 25456100 Free PMC article. Review. - Understanding organ dysfunction in Ebola virus disease.
Fletcher TE, Fowler RA, Beeching NJ. Fletcher TE, et al. Intensive Care Med. 2014 Dec;40(12):1936-9. doi: 10.1007/s00134-014-3515-1. Epub 2014 Nov 1. Intensive Care Med. 2014. PMID: 25366120 No abstract available. - Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease.
Kerber R, Krumkamp R, Korva M, Rieger T, Wurr S, Duraffour S, Oestereich L, Gabriel M, Sissoko D, Anglaret X, Malvy D, May J, Županc TA, Muñoz-Fontela C, Günther S. Kerber R, et al. J Infect Dis. 2018 Nov 22;218(suppl_5):S496-S503. doi: 10.1093/infdis/jiy429. J Infect Dis. 2018. PMID: 30101349 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous